Tuesday, January 15, 2013

Friedreich Ataxia: Dysarthria Profile and Clinical Data.

›
Friedreich Ataxia: Dysarthria Profile and Clinical Data. Brendel B, Ackermann H, Berg D, Lindig T, Schölderle T, Schöls L, Synofzik M, Zieg...
Friday, January 11, 2013

NAF Funded Research for FA in 2013

›
NAF Funded Research for FA in 2013 . Research Grants : Generation of peripheral sensory neurons from Friedreich’s ataxia human iPS cell ...

Seminar at SWOSU: “The Role of Frataxin in the Neurodegenerative Disease Friedreich’s Ataxia”

›
Seminar at SWOSU: “The Role of Frataxin in the Neurodegenerative Disease Friedreich’s Ataxia” . January 10, 2013, Dr. Laura Busenlehner, as...
Wednesday, January 9, 2013

STATegics, Inc. Announces a New Grant from Friedreich’s Ataxia Research Alliance

›
STATegics, Inc. Announces a New Grant from Friedreich’s Ataxia Research Alliance . PRLog (Press Release) - Jan. 8, 2013 - Menlo Park, Califo...
Monday, January 7, 2013

Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Friedreich's Ataxia Clinical Trial

›
Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Friedreich's Ataxia Clinical Trial . PR Newswire, Press release Jan. 7,...
Saturday, January 5, 2013

Somatosensory Temporal Discrimination Threshold Is Increased in Patients with Cerebellar Atrophy

›
Somatosensory Temporal Discrimination Threshold Is Increased in Patients with Cerebellar Atrophy . Fiore Manganelli, Raffaele Dubbioso, Chi...
Friday, January 4, 2013

NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks

›
NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks . Suhas V Vasaikar, Aditya K Padhi, B...

In Epigenomics, Location Is Everything: Researchers Exploit Gene Position to Test 'Histone Code'

›
In Epigenomics, Location Is Everything: Researchers Exploit Gene Position to Test 'Histone Code ' . Menzies Chen, Katherine Licon, R...
Saturday, December 29, 2012

RNA-mediated toxicity in neurodegenerative disease

›
RNA-mediated toxicity in neurodegenerative disease . Veronique V. Belzil, Tania F. Gendron, Leonard Petrucelli. Molecular and Cellular Neuro...
Friday, December 28, 2012

ViroPharma is set to initiate VP20629 Phase II trial in the second half of 2013

›
ViroPharma is set to initiate VP20629 Phase II trial in the second half of 2013 ViroPharma: Strengthening Financial Profile & Pipeline...